Mersana Therapeutics Announces Research Collaboration and Commercial License Agreement with Merck KGaA, Darmstadt, Germany to Develop Novel Immunosynthen Antibody-Drug Conjugates
Collaboration focuses on discovering novel STING-agonist ADCs for up to two targets leveraging Mersana’s proprietary…
ChronoTech AI Inc. Launches Intelligent Robotics Platform
STRATUM Launches Strategic Asset Intelligence Platform for African Mining and EV Battery Minerals
FWD Group marks 13 years with charitable grants benefitting over 13,000 people across Asia
Kincora Reports June 2026 Quarterly Activities and Financial Results
CALB Announces Positive Profit Alert